NASDAQ:ICU SeaStar Medical (ICU) Stock Price, News & Analysis $4.80 +0.01 (+0.21%) Closing price 07/14/2026 04:00 PM EasternExtended Trading$4.78 -0.02 (-0.42%) As of 07/14/2026 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About SeaStar Medical Stock (NASDAQ:ICU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SeaStar Medical alerts:Sign Up Key Stats Today's Range$4.60▼$5.0150-Day Range$2.63▼$5.0852-Week Range$2.07▼$12.50Volume66,857 shsAverage Volume107,694 shsMarket Capitalization$19.20 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingHold Company Overview SeaStar Medical, Inc. (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies. The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR. TriGUARD 3 features an advanced frame and filter design that conforms to varying patient anatomies, enabling physicians to position the device safely and effectively without obstructing critical arterial access routes. SeaStar Medical continues to invest in clinical trials and registry studies to demonstrate the safety and performance of its technology and to support regulatory clearances in North America, Europe and other key markets. Headquartered in Kansas City, Missouri, SeaStar Medical serves a global customer base through direct sales and distribution partnerships in Europe and parts of Asia Pacific, in addition to its U.S. operations. The company collaborates with interventional cardiologists, cardiac surgeons and research institutions to refine device design and expand indications. Its leadership team brings extensive experience from leading cardiovascular and medical device firms, guiding SeaStar Medical through product development, regulatory interactions and market introduction efforts to address the growing demand for neuroprotection in structural heart care.AI Generated. May Contain Errors. Read More SeaStar Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScoreICU MarketRank™: SeaStar Medical scored higher than 66% of companies evaluated by MarketBeat, and ranked 292nd out of 853 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingSeaStar Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialSeaStar Medical has a consensus price target of $8.00, representing about 66.7% upside from its current price of $4.80.Amount of Analyst CoverageSeaStar Medical has only been the subject of 2 research reports in the past 90 days.Read more about SeaStar Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for SeaStar Medical are expected to grow in the coming year, from ($3.58) to ($2.09) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of SeaStar Medical is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SeaStar Medical is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSeaStar Medical has a P/B Ratio of 1.75. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about SeaStar Medical's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.06% of the float of SeaStar Medical has been sold short.Short Interest Ratio / Days to CoverSeaStar Medical has a short interest ratio ("days to cover") of 1.09, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SeaStar Medical has recently decreased by 36.66%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSeaStar Medical does not currently pay a dividend.Dividend GrowthSeaStar Medical does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.99 News SentimentSeaStar Medical has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for SeaStar Medical this week, compared to 2 articles on an average week.Search Interest1 people have searched for ICU on MarketBeat in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, SeaStar Medical insiders have not sold or bought any company stock.Percentage Held by Insiders0.70% of the stock of SeaStar Medical is held by insiders.Percentage Held by Institutions1.69% of the stock of SeaStar Medical is held by institutions.Read more about SeaStar Medical's insider trading history. Receive ICU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SeaStar Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ICU Stock News HeadlinesSeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)July 14 at 8:34 AM | globenewswire.comSeaStar Medical Launches Executive Retention Bonus ProgramJuly 10, 2026 | theglobeandmail.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.July 15 at 1:00 AM | Banyan Hill Publishing (Ad)SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney InjuryJune 23, 2026 | globenewswire.comSeaStar Medical to Present at Upcoming Investor Summit ConferenceJune 22, 2026 | globenewswire.comICU Medical's General Counsel Sells — The Smiths Integration Is Almost Done, the Proof Isn'tICU Medical's General Counsel Sells — The Smiths Integration Is still playing out.June 10, 2026 | fool.comICU: YoY revenue increases 69%May 18, 2026 | msn.comSeaStar Medical Holding Corp (ICU) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...May 14, 2026 | finance.yahoo.comSee More Headlines ICU Stock Analysis - Frequently Asked Questions How have ICU shares performed this year? SeaStar Medical's stock was trading at $2.40 at the beginning of 2026. Since then, ICU stock has increased by 100.0% and is now trading at $4.80. How were SeaStar Medical's earnings last quarter? SeaStar Medical Holding Corporation (NASDAQ:ICU) issued its quarterly earnings results on Wednesday, May, 13th. The company reported ($0.90) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.83) by $0.08. The company had revenue of $0.50 million for the quarter, compared to analyst estimates of $0.44 million. SeaStar Medical had a negative trailing twelve-month return on equity of 146.29% and a negative net margin of 828.62%. Read the conference call transcript. When did SeaStar Medical's stock split? SeaStar Medical shares reverse split on Monday, January 5th 2026.The 1-10 reverse split was announced on Tuesday, December 23rd 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, January 2nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of SeaStar Medical? Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of SeaStar Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that SeaStar Medical investors own include Meta Platforms (META), Pfizer (PFE), Energy Transfer (ET), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI) and Visa (V). Company Calendar Last Earnings5/13/2026Today7/15/2026Next Earnings (Estimated)8/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (8m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 ICU's financial health is in the Yellow zone, according to TradeSmith. ICU has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNASDAQ:ICU CIK1831868 Webseastarmedical.com Phone844-427-8100FaxN/AEmployees2Year FoundedN/APrice Target and Rating Average Price Target for SeaStar Medical$8.00 High Price Target$8.00 Low Price Target$8.00 Potential Upside/Downside+66.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($4.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.15 million Net Margins-828.62% Pretax Margin-828.41% Return on Equity-146.29% Return on Assets-96.48% Debt Debt-to-Equity RatioN/A Current Ratio2.73 Quick Ratio2.71 Sales & Book Value Annual Sales$1.23 million Price / Sales15.61 Cash FlowN/A Price / Cash FlowN/A Book Value$2.75 per share Price / Book1.75Miscellaneous Outstanding Shares4,000,000Free Float3,969,000Market Cap$19.20 million OptionableNot Optionable Beta-1.05 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:ICU) was last updated on 7/15/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SeaStar Medical Holding Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share SeaStar Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
